Fatty liver disease (MASLD/MASH): open trials in Chile

• NCT06632444

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  Trial Treatment · Phase 3 · Boehringer Ingelheim

  Edificio Fleming, La Serena · Centro de Investigaciones Medicas UC, Santiago · Centro de Investigaciones Clinicas Vina Del Mar, Viña del Mar

  Registry updated 2026-10-28

• NCT06632457

  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  Trial Treatment · Phase 3 · Boehringer Ingelheim

  Edificio Fleming, La Serena · Centro de Investigaciones Medicas UC, Santiago · Centro de Investigaciones Clinicas Vina Del Mar, Viña del Mar

  Registry updated 2026-10-28

• NCT06528314

  A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

  Trial Treatment · Phase 3 · Akero Therapeutics, Inc

  Las Condes · La Serena · Santiago

  Registry updated 2026-10-13

• NCT05618626

  Prevention of NAFLD and CVD Through Lifestyle Intervention

  Trial Treatment · Pontificia Universidad Catolica de Chile

  Centro MAUCO+, Molina

  Registry updated 2024-11-19

All Fatty liver disease (MASLD/MASH) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error